In Part II our Speaker, Dr. Andreas Marx, head of the clinical department at mdc, will discuss critical aspects of additional documentation which is under clinical review such as the IFU, PMCF plan and the SSCP.

The seminar is intended for professionals of the medical device industry dealing with class III (high risk) products and implantables: Personal of Clinical Affairs, Regulatory Affairs, Quality Management and others involved in the Clinical Evaluation. This is not a seminar for beginners.

• PMCF as a substantial contribution to the CER
• Additional documentation under clinical review: IFU, PMCF Plan, SSCP
• Key elements of a literature search

Participant discount: From the 2nd participant you will receive a discount of 15% and from the 5th participant 25% on the net price.

Customer discount: mdc customers receive a 10% discount on the net price.

Participant and customer discounts cannot be combined! The discount will be deducted automatically if a booking concerns employees of the same company and the same seminar.

Please note that the registration fee and the associated participation only applies to one person. If several people take part in the remote-seminar, although only one person has registered, we reserve the right to exclude the further persons from the seminar.

450.00 Euro (plus value added tax)